AstraZeneca Halts £200m Investment in Cambridge Research
AstraZeneca has paused a £200m investment in a Cambridge research site, part of a broader trend of reduced UK pharmaceutical investment amid government support cuts and increased US focus, impacting jobs and research expansion in the UK.